{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:28:39Z","timestamp":1786368519763,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"DOI":"10.1007\/s00246-026-04418-6","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:34:42Z","timestamp":1786365282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Passive Congestion: The Inflammatory Gut\u2013Liver Axis in Fontan Circulation"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9396-7178","authenticated-orcid":false,"given":"Ashish H.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Ravandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"4418_CR1","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1161\/CIR.0000000000000696","volume":"140","author":"J Rychik","year":"2019","unstructured":"Rychik J, Atz AM, Celermajer DS, Deal BJ, Gatzoulis MA, Gewillig MH, Hsia TY, Hsu DT, Kovacs AH, McCrindle BW, Newburger JW, Pike NA, Rodefeld M, Rosenthal DN, Schumacher KR, Marino BS, Stout K, Veldtman G, Younoszai AK, d\u2019Udekem Y, American Heart Association Council on Cardiovascular Disease in the Young and Council on Cardiovascular and Stroke Nursing (2019) Evaluation and management of the child and adult with fontan circulation: a scientific statement from the American Heart Association. Circulation 140:e234","journal-title":"Circulation"},{"key":"4418_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2024.101563","volume":"4","author":"AH Shah","year":"2025","unstructured":"Shah AH, Surendran A, Hassan-Tash P, Turnbull CN, Johnston N, Goodlett D, Han J, Ducas RA, Tam JW, Renner E, Duhamel TA, Aliani M, Ravandi A, Krasuski RA (2025) Association of Fontan pathophysiology with plasma bile acids. JACC Adv 4:101563","journal-title":"JACC Adv"},{"key":"4418_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.102203","volume":"4","author":"AH Shah","year":"2025","unstructured":"Shah AH (2025) Fontan-associated diastolic dysfunction and bile acids: mechanistic parallels with cirrhotic cardiomyopathy. JACC Adv 4:102203","journal-title":"JACC Adv"},{"issue":"1","key":"4418_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40659-023-00436-3","volume":"56","author":"J Abrigo","year":"2023","unstructured":"Abrigo J, Olguin H, Tacchi F, Orozco-Aguilar J, Valero-Breton M, Soto J, Castro-Sepulveda M, Elorza AA, Simon F, Cabello-Verrugio C (2023) Cholic and deoxycholic acids induce mitochondrial dysfunction, impaired biogenesis and autophagic flux in skeletal muscle cells. Biol Res 56:30","journal-title":"Biol Res"},{"key":"4418_CR5","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","volume":"58","author":"G Kakiyama","year":"2013","unstructured":"Kakiyama G, Pandak WM, Gillevet PM, Hylemon PB, Heuman DM, Daita K, Takei H, Muto A, Nittono H, Ridlon JM, White MB, Noble NA, Monteith P, Fuchs M, Thacker LR, Sikaroodi M, Bajaj JS (2013) Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J Hepatol 58:949\u2013955","journal-title":"J Hepatol"},{"key":"4418_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15090592","author":"A Surendran","year":"2025","unstructured":"Surendran A, Ravandi A, Shah AH (2025) Plasma lipidomic alterations in Fontan circulation reflect cardiovascular functional reserve. Metabolites. https:\/\/doi.org\/10.3390\/metabo15090592","journal-title":"Metabolites"},{"key":"4418_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2025.11.046","author":"AH Shah","year":"2025","unstructured":"Shah AH (2025) Fontan circulation beyond preload: metabolic pathways and mitochondrial stress. Can J Cardiol. https:\/\/doi.org\/10.1016\/j.cjca.2025.11.046","journal-title":"Can J Cardiol"},{"key":"4418_CR8","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1001\/jamacardio.2019.5459","volume":"5","author":"W Budts","year":"2020","unstructured":"Budts W, Ravekes WJ, Danford DA, Kutty S (2020) Diastolic heart failure in patients with the fontan circulation: a review. JAMA Cardiol 5:590\u2013597","journal-title":"JAMA Cardiol"},{"key":"4418_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/hep.28890","volume":"65","author":"MS Desai","year":"2017","unstructured":"Desai MS, Mathur B, Eblimit Z, Vasquez H, Taegtmeyer H, Karpen SJ, Penny DJ, Moore DD, Anakk S (2017) Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart. Hepatology 65:189\u2013201","journal-title":"Hepatology"},{"key":"4418_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.034538","volume":"13","author":"H Ohuchi","year":"2024","unstructured":"Ohuchi H, Asano R, Mori A, Ishibashi T, Motooka D, Nakai M, Nakaoka Y (2024) Gut dysbiosis in patients with Fontan circulation. J Am Heart Assoc 13:e034538","journal-title":"J Am Heart Assoc"},{"key":"4418_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.70405","author":"AH Shah","year":"2026","unstructured":"Shah AH, Liu Y, Armstrong HK, Han J, Goodlett DR, Ravandi A, Dhingra S (2026) Association of Fontan circulation with gut microbiome derived straight and branched short chain fatty acids. J Gastroenterol Hepatol. https:\/\/doi.org\/10.1111\/jgh.70405","journal-title":"J Gastroenterol Hepatol"},{"key":"4418_CR12","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3945\/jn.109.104638","volume":"139","author":"L Peng","year":"2009","unstructured":"Peng L, Li ZR, Green RS, Holzman IR, Lin J (2009) Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr 139:1619\u20131625","journal-title":"J Nutr"},{"key":"4418_CR13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/liv.14375","volume":"40","author":"E Rodriguez de Santiago","year":"2020","unstructured":"Rodriguez de Santiago E, Tellez L, Garrido-Lestache Rodriguez-Monte E, Garrido-Gomez E, Aguilera-Castro L, Alvarez-Fuente M, Del Cerro MJ, Albillos A (2020) Fontan protein-losing enteropathy is associated with advanced liver disease and a proinflammatory intestinal and systemic state. Liver Int 40:638\u2013645","journal-title":"Liver Int"},{"key":"4418_CR14","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2025-0238","author":"AK Bagchi","year":"2026","unstructured":"Bagchi AK, Liu Y, Dhingra S, Ravandi A, Shah AH (2026) Association of stromal cell derived factor 1\u03b1 and interferon-\u03b3 induced protein 10 with Fontan pathophysiology. Can J Physiol Pharmacol. https:\/\/doi.org\/10.1139\/cjpp-2025-0238","journal-title":"Can J Physiol Pharmacol"},{"key":"4418_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-026-04370-5","author":"AH Shah","year":"2026","unstructured":"Shah AH, Ravandi A (2026) Selective activation of the tryptophan-kynurenine pathway in Fontan circulation. Pediatr Cardiol. https:\/\/doi.org\/10.1007\/s00246-026-04370-5","journal-title":"Pediatr Cardiol"},{"key":"4418_CR16","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1111\/febs.16086","volume":"289","author":"MT Pallotta","year":"2022","unstructured":"Pallotta MT, Rossini S, Suvieri C, Coletti A, Orabona C, Macchiarulo A, Volpi C, Grohmann U (2022) Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme. FEBS J 289:6099\u20136118","journal-title":"FEBS J"},{"key":"4418_CR17","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1016\/j.ijcard.2013.06.008","volume":"168","author":"RW Elder","year":"2013","unstructured":"Elder RW, McCabe NM, Hebson C, Veledar E, Romero R, Ford RM, Mahle WT, Kogon BE, Sahu A, Jokhadar M, McConnell ME, Book WM (2013) Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study. Int J Cardiol 168:3764\u20133769","journal-title":"Int J Cardiol"},{"key":"4418_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1136\/heartjnl-2022-321435","volume":"109","author":"I Martin de Miguel","year":"2023","unstructured":"Martin de Miguel I, Kamath PS, Egbe AC, Jain CC, Cetta F, Connolly HM, Miranda WR (2023) Haemodynamic and prognostic associations of liver fibrosis scores in Fontan-associated liver disease. Heart 109:619\u2013625","journal-title":"Heart"},{"key":"4418_CR19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jacc.2023.12.005","volume":"83","author":"K Bravo-Jaimes","year":"2024","unstructured":"Bravo-Jaimes K, Wu X, Reardon LC, Lluri G, Lin JP, Moore JP, van Arsdell G, Biniwale R, Si MS, Naini BV, Venick R, Saab S, Wray CL, Ponder R, Rosenthal C, Klomhaus A, Bostrom KI, Aboulhosn JA, Kaldas FM (2024) Intrahepatic transcriptomics differentiate advanced fibrosis and clinical outcomes in adults with Fontan circulation. J Am Coll Cardiol 83:726\u2013738","journal-title":"J Am Coll Cardiol"},{"key":"4418_CR20","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","volume":"72","author":"A Albillos","year":"2020","unstructured":"Albillos A, de Gottardi A, Rescigno M (2020) The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol 72:558\u2013577","journal-title":"J Hepatol"},{"key":"4418_CR21","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jhep.2023.07.014","volume":"79","author":"AJ Sanyal","year":"2023","unstructured":"Sanyal AJ, Ratziu V, Loomba R, Anstee QM, Kowdley KV, Rinella ME, Sheikh MY, Trotter JF, Knapple W, Lawitz EJ, Abdelmalek MF, Newsome PN, Boursier J, Mathurin P, Dufour JF, Berrey MM, Shiff SJ, Sawhney S, Capozza T, Leyva R, Harrison SA, Younossi ZM (2023) Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis. J Hepatol 79:1110\u20131120","journal-title":"J Hepatol"},{"key":"4418_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2025.08.011","author":"AH Shah","year":"2025","unstructured":"Shah AH, Armstrong HK, Mittal I, Reimer A, Kunutsor SK, Ducas RA, Alizadeh K, Tam JW, Ravandi A, Dhingra S (2025) IMpact of therapY using coleSevelam treatment reducing bile acids in patients with fonTan cIrCulation (MYSTIC): rationale and study design. Am Heart J. https:\/\/doi.org\/10.1016\/j.ahj.2025.08.011","journal-title":"Am Heart J"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-026-04418-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-026-04418-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-026-04418-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:34:43Z","timestamp":1786365283000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-026-04418-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":22,"alternative-id":["4418"],"URL":"https:\/\/doi.org\/10.1007\/s00246-026-04418-6","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"9 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}